A phase 3b Study to evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Woman with Documented Endometrioos and Associated Moderate to Severe Pain.
18 month Study with 9 study visits.
Testing will include but not limited to Labs, Pelvic Exams, with PAP Smears, Physical Exams, ECG's, Transvaginal Ultrasounds, DEXA's, Mammograms (39 years old or older). No Cost to Patient, NO INSURANCE NEEDED.